论文部分内容阅读
原发性肝癌(以下简称肝癌)是我国重点防治的九种主要恶性肿瘤之一。据死因调查表明,我国每年有十一万人死于肝癌,仅次于胃癌和食管癌,居恶性肿瘤死因的第三位,在世界上属高死亡水平的国家,我国肝癌病例占世界所有病例的45％。近二十年来,我国逐步在肝癌高发区(启东、扶绥等地)建立了综合性防治区和科研机构,在此基础上进行了一系列的研究,特别是近年来
Primary liver cancer (hereinafter referred to as liver cancer) is one of the nine major malignant tumors that we focus on prevention and treatment. According to the investigation of the cause of death, there are 110,000 people who die of liver cancer each year in our country, second only to stomach cancer and esophageal cancer, ranking third in the cause of death of malignant tumors. In countries with a high death level in the world, all cases of liver cancer in our country account for all cases in the world Of 45%. In the recent two decades, China has gradually established a comprehensive prevention and control area and research institutes in areas with a high incidence of liver cancer (Qidong and Fusui, etc.). Based on this, a series of studies have been conducted, especially in recent years